Study identifier:NIS-CRU-ATA-2008/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Analysis of antihypertensive treatment efficacy
Arterial Hypertension
-
No
-
All
2000
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
Analysis of antihypertensive treatment efficacy.
Location
Location
Arhangelsk, Russian Federation
Location
Bryansk, Russian Federation
Location
Domodedovo, Russian Federation
Location
Dzerzhinsk, Russian Federation
Location
Ekaterinburg, Russian Federation
Location
Essentuki, Russian Federation
Location
Georgievsk, Russian Federation
Location
Irkutsk, Russian Federation
Arms | Assigned Interventions |
---|---|
1 Male or female with arterial hypertension | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.